Niraparib Suppliers & Bulk Manufacturers
Available Forms: Capsule/ Tablet
Available Strengths: 100 mg, 200 mg, 300 mg
Reference Brands: Zejula (USA/EU)
Category:
Oncology Cancer Care
Niraparib is an oral PARP inhibitor used for the treatment and maintenance of advanced ovarian, fallopian tube, or primary peritoneal cancer. It works by blocking the PARP enzyme, which helps repair DNA damage in cancer cells, leading to cell death, especially in tumors with BRCA mutations or homologous recombination deficiency (HRD). Niraparib is available in capsules or tablets and is taken once daily, with the dose adjusted based on body weight and platelet count. It helps delay cancer progression and is generally used after platinum-based chemotherapy.
Niraparib is available in Capsule/ Tablet
and strengths such as 100 mg, 200 mg, 300 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Niraparib is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Niraparib can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing